Info
Insider Ownership

Insider Trading & Ownership of F2 Bioscience I 2017 Ltd

Location: Geneva, Switzerland
Summary: The estimated value of insider holdings of F2 Bioscience I 2017 Ltd is at least $55,209,813 dollars as of 23 Jun 2022. F2 Bioscience I 2017 Ltd is the 10%+ Owner of Cullinan Oncology, Inc. and owns shares of Cullinan Therapeutics, Inc. (CGEM) stock worth about $55.21M.
Signature: /s/ Rachel Higham /s/ Ivan Bedford, for F2 Bioscience I 2017 Limited
All Insider Reports: All Insider Reports

Notify me when F2 Bioscience I 2017 Ltd files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of F2 Bioscience I 2017 Ltd

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
CGEM	Cullinan Therapeutics, Inc.	10%+ Owner	$55,209,813			21 Jun 2022

Insider Transactions Reported by F2 Bioscience I 2017 Ltd:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.